Genome-scale functional profiling of the mammalian AP-1 signaling pathwaySumit K. Chanda, Jeremy S. Caldwell, Paul DeJesus et al.|Proceedings of the National Academy of Sciences|2003Cited by 110
Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disordersSara M. Fielder, Stephen C. Pak, Marisa W. Friederich et al.|EMBO Molecular Medicine|2025Cited by 8
Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disordersSara M. Fielder, Stephen C. Pak, Marisa W. Friederich et al.|medRxiv|2025Cited by 1